Oncology Imaging - Tumour Response Assessment with RECIST and Beyond is organized by TMC Academy and will be held from Mar 19 - 21, 2025.
Description:
The purpose of this cancer imaging fellowship is to provide a comprehensive overview of imaging criteria (RECIST 1.1 in particular) to assess tumour response in patients receiving systemic therapy. RECIST 1.1 criteria are widely used in clinical trials comparing the efficacy of several therapeutic strategies.
Response Evaluation Criteria in Solid Tumors (RECIST) is a set of standardized guidelines for assessing treatment response in solid tumours.
A thorough understanding of these criteria principles and subtleties is important for radiologists involved in clinical trials. Outside clinical trials, RECIST 1.1 can also be used for more comfortable interpretation of images, with structured reporting, to better communicate with oncologists. With the arrival of new, more targeted treatments in oncology, the RECIST criteria had to be adapted and new criteria developed, such as iRECIST for immunotherapy.
Each module starts with a lecture. After the lecture, you will be challenged to practise on key clinical cases. After and during the individual case readings there will be plenty of time for group discussion and Q&A with Dr. Caramella.
Learning Objectives:
Programme will Include:
This course has been approved for a maximum of 9 EACCME CME Credits.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved